Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer

NCT06001528 is registered in ClinicalTrials.gov with Shantou Central Hospital as lead sponsor.

NCT NCT06001528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06001528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer
Lead sponsor
Shantou Central Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2021
Completion date
August 31, 2026
Enrollment
2,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lymph node metastasis